Bio-Techne Corp.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $126.2M | $76.1M | $104.5M | $107.7M | $110.9M | $112.6M | $112.3M | $112.3M |
| Depreciation & Amortization | $64.5M | $60.0M | $42.8M | $37.2M | $19.2M | $12.3M | $12.5M | $8.7M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $47.1M | $44.4M | $29.4M | — | — | — | — | — |
| Stock-Based Compensation | $28.2M | $14.6M | $9.4M | $6.0M | $3.5M | $1.9M | — | — |
| Net Cash from Operating Activities | $170.4M | $143.7M | $144.2M | $139.4M | $136.8M | $123.6M | $126.7M | $127.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $20.9M | $15.2M | $16.9M | $19.9M | $13.8M | $22.5M | $6.0M | $3.6M |
| Business Acquisitions | $67.9M | $253.8M | $91.4M | $420.1M | $109.2M | $0 | $0 | $131.8M |
| Net Cash from Investing Activities | $-38.7M | $-306.0M | $-107.6M | — | — | $-31.2M | $-21.7M | $-114.2M |
| Financing Activities | ||||||||
| Dividends Paid | $48.0M | $47.3M | $47.6M | $47.1M | $45.4M | $43.5M | $41.0M | $39.7M |
| Stock Repurchases | $0 | — | — | $0 | $0 | $1.8M | $23.6M | $1.9M |
| Net Cash from Financing Activities | $-99.2M | $189.1M | $-23.4M | — | — | $-44.7M | $-64.6M | $-36.3M |
| Net Change in Cash | $30.4M | $27.4M | $9.7M | $-264.0M | $154.8M | $47.1M | $39.1M | $-16.5M |
| Free Cash Flow | $149.4M | $128.5M | $127.3M | $119.5M | $122.9M | $101.1M | $120.7M | $123.6M |